Correlation between inflammatory cells (T and B lymphocytes, macrophages) in prostate biopsies and elevated PSA levels in a PSA screening population

Urology

Volumn 59, Issue 1, 2002, Pages 68-72

  Moser, Patrizia L ^a   Brunner, Andrea ^a   Horninger, Wolfgang ^a   Bartsch, Georg ^a   Mikuz, Gregor ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; MORPHOMETRICS; PATIENT; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; SCREENING; STROMA; T LYMPHOCYTE; ULTRASOUND;

ADULT; AGED; B-LYMPHOCYTES; BIOPSY; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; T-LYMPHOCYTES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0036142109     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01493-5     Document Type: Article

References (24)

1. Incidental lymphocytic prostatitis; selective involvement with nonmalignant glands
2. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
3. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
4. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia
5. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer
6. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia
7. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer
8. Prostate cancer screening in the Tyrol, Austria; experience and results
9. Characterisation of inflammatory cells in benign prostatic hyperplasia
10. Methods for the quantitative morphologic analysis of tissues
11. A review of clinical and pathological prostatitis syndromes
12. Patterns of inflammation in prostatic hyperplasia; a histologic and bacteriologic study
13. Prostate-specific antigen levels in acute and chronic bacterial prostatitis
14. Serum prostate specific antigen levels in non-specific granulomatous prostatitis
15. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis; correlation with total serum PSA and PSA density
16. Inflammation in benign prostatic hyperplasia; correlation with prostate specific antigen value
17. Consensus development of a histopathological classification system for chronic prostatic inflammation
18. Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitro
19. Cloning and characterization of the alpha 1-antichymotrypsin produced by human prostate tissue
20. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia
21. Proliferative inflammatory atrophy of the prostate; implications for prostatic carcinogenesis